These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 896840)

  • 21. Metabolism of carbidopa (1-(-)-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate), an aromatic amino acid decarboxylase inhibitor, in the rat, rhesus monkey, and man.
    Vickers S; Stuart EK; Bianchine JR; Hucker HB; Jaffe ME; Rhodes RE; Vandenheuvel WJ
    Drug Metab Dispos; 1974; 2(1):9-22. PubMed ID: 4150141
    [No Abstract]   [Full Text] [Related]  

  • 22. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
    Buck K; Ferger B
    Neurobiol Dis; 2008 Feb; 29(2):210-20. PubMed ID: 17920284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
    Tyce GM
    J Neurochem; 1976 Dec; 27(6):1397-403. PubMed ID: 1003214
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of stimulation and blockade of the dopaminergic system on the choice of behavioral strategy by rats in the shuttle box].
    Butenko OB; Kordzadze RN; Barsegian GG
    Biull Eksp Biol Med; 1992 Dec; 114(12):573-4. PubMed ID: 1292674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoamine precursors and copulatory behavior in the male rat.
    Malmnäs CO
    Acta Physiol Scand Suppl; 1973; 400():47-68. PubMed ID: 4546480
    [No Abstract]   [Full Text] [Related]  

  • 26. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
    J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Our experience in the treatment of Parkinson's disease with L-dopa plus RO 4-4602 combination].
    Campanella G; Pennetta R
    Acta Neurol (Napoli); 1974; 29(3):252-63. PubMed ID: 4417098
    [No Abstract]   [Full Text] [Related]  

  • 28. Attraction to ethanol solutions in mice: induction by a tetrahydroisoquinoline derivative of L-DOPA.
    Collins MA; Kahn AJ
    Subst Alcohol Actions Misuse; 1982; 3(5):299-302. PubMed ID: 7167865
    [No Abstract]   [Full Text] [Related]  

  • 29. Apomorphine and L-DOPA lower ejaculation threshold in the male rat.
    Paglietti E; Quarantotti BP; Mereu G; Gessa GL
    Physiol Behav; 1978 May; 20(5):559-62. PubMed ID: 684090
    [No Abstract]   [Full Text] [Related]  

  • 30. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ; Kerwin L
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
    Streifler M; Vardi J; Kesten M
    Harefuah; 1972 Nov; 83(9):362-4. PubMed ID: 4669737
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of Parkinson's syndromes by a combination of levodopa with decarboxylase inhibitors].
    Hanzal F
    Cesk Neurol Neurochir; 1975 Dec; 38(6):327-32. PubMed ID: 1192544
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible mechanism of adverse reaction following levodopa plus benserazide treatment.
    Messiha FS
    Br J Pharmacol; 1977 May; 60(1):55-7. PubMed ID: 884390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depletion of 5-HT by L-DOPA in spinal cord and brainstem of rat.
    Commissiong JW; Sedgwick EM
    Life Sci; 1979 Jul; 25(1):83-6. PubMed ID: 481125
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of L-dopa on exploratory activity after catecholamine receptors blocking agents.
    Maj J; Pawlowski L
    Pol J Pharmacol Pharm; 1974; 26(6):633-8. PubMed ID: 4445053
    [No Abstract]   [Full Text] [Related]  

  • 36. Reinstatement of vaginal cycles in aged female rats.
    Linnoila M; Cooper RL
    J Pharmacol Exp Ther; 1976 Nov; 199(2):477-82. PubMed ID: 988180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA; Mattern C; Häcker R; Tomaz C; Huston JP; Schwarting RK
    Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitors.
    Kersting F; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):547-55. PubMed ID: 322921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative 90-day toxicity of two decarboxylase inhibitors, benserazide and carbidopa, in the rat.
    Rauws AG; Vos JG; Garbis-Berkvens JM; Peters PW; de Vries T; van Logten MJ
    Toxicol Appl Pharmacol; 1982 Nov; 66(2):201-20. PubMed ID: 7164099
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.